Evidence map›Paper›PMID 35670041›Full record

ReviewMass spectrometry reviews2023

Mass spectrometry-based retina proteomics.

Laszlo Prokai, Khadiza Zaman, Katalin Prokai-Tatrai

Open access · greenAbstract readReview
In one paragraph

Review in Mass spectrometry reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Laszlo ProkaiDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, USA.ORCID 0000-0002-4559-3458
Khadiza ZamanDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, USA.ORCID 0000-0003-4876-765X
Katalin Prokai-TatraiDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas, USA.ORCID 0000-0001-5595-1346
University of North Texas · US

Funding

A Novel Neuroprotective Approach for GlaucomaR01EY027005 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI KATALIN T PROKAI · 2016 to 2026
$3.9M
NEI NIH HHS R01 EY027005
6 · The paper itself

Abstract

A subfield of neuroproteomics, retina proteomics has experienced a transformative growth since its inception due to methodological advances in enabling chemical, biochemical, and molecular biology techniques. This review focuses on mass spectrometry's contributions to facilitate mammalian and avian retina proteomics to catalog and quantify retinal protein expressions, determine their posttranslational modifications, as well as its applications to study the proteome of the retina in the context of biology, health and diseases, and therapy developments.

Indexed as

ProteomeProteomicsAnimalsMammalsMass SpectrometryProtein Processing, Post-TranslationalRetinaProteomebiomarkersestrogenic retinaphotobiologyposttranslational modificationsprotein expressionproteomicsretinaretinal diseasestherapeutic targets

Identifiers

PMID35670041
PMCPMC9730434
OpenAlexW4281640567

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.